The association of megalin and cubilin genetic variants with serum levels of 25-hydroxvitamin D and the incidence of acute coronary syndrome in Egyptians: A case control study

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorElsabbagh R.A.
dc.contributor.authorAbdel Rahman M.F.
dc.contributor.authorHassanein S.I.
dc.contributor.authorHanafi R.S.
dc.contributor.authorAssal R.A.
dc.contributor.authorShaban G.M.
dc.contributor.authorGad M.Z.
dc.contributor.otherClinical Biochemistry Unit
dc.contributor.otherFaculty of Pharmacy and Biotechnology
dc.contributor.otherThe German University in Cairo
dc.contributor.otherEgypt; Biochemistry Department
dc.contributor.otherFaculty of Pharmacy
dc.contributor.otherOctober University for Modern Science and Arts
dc.contributor.other6th of October City
dc.contributor.otherEgypt; Department of Pharmaceutical Chemistry
dc.contributor.otherFaculty of Pharmacy and Biotechnology
dc.contributor.otherThe German University in Cairo
dc.contributor.otherEgypt; Department of Pharmacology and Toxicology
dc.contributor.otherFaculty of Pharmacy and Biotechnology
dc.contributor.otherThe German University in Cairo
dc.contributor.otherEgypt; National Heart Institute
dc.contributor.otherCairo
dc.contributor.otherEgypt
dc.date.accessioned2020-01-09T20:40:29Z
dc.date.available2020-01-09T20:40:29Z
dc.date.issued2020
dc.descriptionScopus
dc.description.abstractMegalin and cubilin are two receptors that mediate endocytosis of 25-hydroxyvitamin D (25(OH)D) for its final activation by hydroxylation. The aim of the present study was to evaluate the association of polymorphisms in megalin (rs2075252 and rs4668123) and cubilin (rs1801222 and rs12766939) with the circulating serum levels of 25(OH)D and with the early incidence of acute coronary syndrome (ACS) in Egyptians. The study included 328 subjects; 185 ACS patients aged between 27 and 60 years, and 143 healthy age-matched controls. Genotyping of cubilin rs12766939 Single Nucleotide Polymorphism (SNP) was performed using Real-Time Polymerase Chain Reaction (qPCR) and for megalin rs4668123 and rs2075252 and cubilin rs1801222 by Polymerase Chain Reaction- Restriction Fragment Length Polymorphism (PCR-RFLP). 25(OH)D levels were measured by Ultra Performance Liquid Chromatography- Tandem Mass Spectroscopy (UPLC-MS/MS). Results showed that vitamin D deficiency was highly linked to ACS incidence (P < 0.0001). The megalin rs4668123 CC, cubilin rs1801222 GG and cubilin rs12766939 GG + GA genotypes are associated with a higher ACS incidence and can be considered risk factors, according to Chi-squared test (P = 0.0003, 0.0442, 0.013 respectively). Conversely, the megalin rs2075252 SNP was not associated with increased ACS incidence. However, after performing multiple logistic regression analysis, only the megalin rs4668123 SNP was considered an independent ACS risk factor. Furthermore, the megalin rs4668123 CC genotype was associated with lower 25(OH)D levels (P = 0.0018). In conclusion, megalin rs4668123 (CC) was linked to lower 25(OH)D levels and can be considered an independent risk factor for incidence of ACS. � 2019en_US
dc.description.urihttps://www.scimagojr.com/journalsearch.php?q=19700168304&tip=sid&clean=0
dc.identifier.doihttps://doi.org/10.1016/j.jare.2019.09.006
dc.identifier.doiPubMed ID :
dc.identifier.issn20901232
dc.identifier.otherhttps://doi.org/10.1016/j.jare.2019.09.006
dc.identifier.otherPubMed ID :
dc.identifier.urihttps://t.ly/w1yE5
dc.language.isoEnglishen_US
dc.publisherElsevier B.V.en_US
dc.relation.ispartofseriesJournal of Advanced Research
dc.relation.ispartofseries21
dc.subjectAcute coronary syndromeen_US
dc.subjectCubilinen_US
dc.subjectEgyptiansen_US
dc.subjectMegalinen_US
dc.subjectPolymorphismsen_US
dc.subjectVitamin D receptoren_US
dc.titleThe association of megalin and cubilin genetic variants with serum levels of 25-hydroxvitamin D and the incidence of acute coronary syndrome in Egyptians: A case control studyen_US
dc.typeArticleen_US
dcterms.isReferencedByBikle, D.D., Vitamin D metabolism, mechanism of action, and clinical applications (2014) Chem Biol, 21 (3), pp. 319-329; Holick, M.F., Vitamin D deficiency (2007) N Engl J Med, 357 (3), pp. 266-281; Holick, M.F., Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis (2004) Am J Clin Nutr, 79 (3), pp. 362-371; DeLuca, H.F., History of the discovery of vitamin D and its active metabolites (2014) BoneKEy Rep, 3; Nair, R., Maseeh, A., Vitamin D: the sunshine vitamin (2012) J Pharmacol Pharmacotherapeutics, 3 (2), pp. 118-126; Arabi, A., El Rassi, R., El-Hajj Fuleihan, G., Hypovitaminosis D in developing countries[mdash]prevalence, risk factors and outcomes (2010) Nat Rev Endocrinol, 6 (10), pp. 550-561; Aljefree, N., Ahmed, F., Prevalence of cardiovascular disease and associated risk factors among adult population in the gulf region: a systematic review (2015) Adv Public Health, 2015, p. 23; Wong, N.D., Epidemiological studies of CHD and the evolution of preventive cardiology (2014) Nat Rev Cardiol, 11 (5), pp. 276-289; Overbaugh, K.J., Acute coronary syndrome (2009) Am J Nurs, 109 (5), pp. 42-52. , quiz 3; Pilz, S., Verheyen, N., Grubler, M.R., Tomaschitz, A., Marz, W., Vitamin D and cardiovascular disease prevention (2016) Nat Rev Cardiol, 13 (7), pp. 404-417; Gunta, S.S., Thadhani, R.I., Mak, R.H., The effect of vitamin D status on risk factors for cardiovascular disease (2013) Nat Rev Nephrol, 9 (6), pp. 337-347; Papandreou, D., Hamid, Z.-T.-N., The role of vitamin D in diabetes and cardiovascular disease: an updated review of the literature (2015) Dis Markers, 2015; Al Mheid, I., Patel, R.S., Tangpricha, V., Quyyumi, A.A., Vitamin D and cardiovascular disease: is the evidence solid? (2013) Eur Heart J; (2013), 59 (6), pp. 479-88. , Abu el Maaty MA, Gad MZ. Vitamin D deficiency and cardiovascular disease: potential mechanisms and novel perspectives. J Nutr Sci Vitaminol (Tokyo); Pilz, S., Gaksch, M., O'Hartaigh, B., Tomaschitz, A., Marz, W., The role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013? (2013) Arch Toxicol, 87 (12), pp. 2083-2103; Beveridge, L.A., Witham, M.D., Vitamin D and the cardiovascular system (2013) Osteoporos Int, 24 (8), pp. 2167-2180; Ku, Y.-C., Liu, M.-E., Ku, C.-S., Liu, T.-Y., Lin, S.-L., Relationship between vitamin D deficiency and cardiovascular disease (2013) World J Cardiol, 5 (9), pp. 337-346; Tsagalis, G., Renal anemia: a nephrologist's view (2011) Hippokratia, 15, pp. 39-43; Maaty, M.A., Ae, Hassanein SI, Gad MZ. Polymorphisms in the Vitamin D pathway in relation to 25-hydroxyvitamin D status and cardiovascular disease incidence: application to biomarkers 2015:1�22; Christensen, E.I., Birn, H., Storm, T., Weyer, K., Nielsen, R., Endocytic receptors in the renal proximal tubule (2012) Physiology, 27 (4), pp. 223-236; Christensen, E.I., Nielsen, R., Birn, H., From bowel to kidneys: the role of cubilin in physiology and disease (2013) Nephrol Dial Transplant, 28 (2), pp. 274-281; Fam, M., Ibrahim, S., Rahman, M., Assal, R., Hanafi, R., Gad, M., Contribution of CYP27B1 and CYP24A1 genetic variations to the incidence of acute coronary syndrome and to Vitamin D serum level (2019) Can J Physiol Pharmacol; Abu el Maaty, M.A., Hanafi, R.S., Aboul-Enein, H.Y., Gad, M.Z., Design-of-experiment approach for HPLC analysis of 25-hydroxyvitamin D: a comparative assay with ELISA (2014) J Chromatogr Sci, 53 (1), pp. 66-72; Gallagher, J.C., Sai, A.J., Vitamin D insufficiency, deficiency, and bone health (2010) J Clin Endocrinol Metab, 95 (6), pp. 2630-2633; Holick, M.F., Chen, T.C., Vitamin D deficiency: a worldwide problem with health consequences (2008) Am J Clin Nutr, 87 (4), pp. 1080S-1086S; Lavie, C.J., Lee, J.H., Milani, R.V., Vitamin D and cardiovascular disease: will it live up to its hype? (2011) J Am Coll Cardiol, 58 (15), pp. 1547-1556; Al Mheid, I., Quyyumi, A.A., Vitamin D and cardiovascular disease: controversy unresolved (2017) J Am Coll Cardiol, 70 (1), pp. 89-100; Marenberg, M.E., Risch, N., Berkman, L.F., Floderus, B., de Faire, U., Genetic susceptibility to death from coronary heart disease in a study of twins (1994) N Engl J Med, 330 (15), pp. 1041-1046; Norman, P.E., Powell, J.T., Vitamin D and cardiovascular disease (2014) Circ Res, 114 (2), pp. 379-393; Wranicz, J., Szostak-Wegierek, D., Health outcomes of vitamin D. Part II. Role in prevention of diseases (2014) Rocz Panstw Zakl Hig, 65 (4), pp. 273-279; Wang, T.J., Pencina, M.J., Booth, S.L., Jacques, P.F., Ingelsson, E., Lanier, K., Vitamin D deficiency and risk of cardiovascular disease (2008) Circulation, 117 (4), pp. 503-511; Melamed, M.L., Michos, E.D., Post, W., Astor, B., 25-hydroxyvitamin D levels and the risk of mortality in the general population (2008) Arch Intern Med, 168 (15), pp. 1629-1637; Dobnig, H., Pilz, S., Scharnagl, H., Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cau
dcterms.sourceScopus

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
avatar_scholar_128.png
Size:
2.73 KB
Format:
Portable Network Graphics
Description:
Loading...
Thumbnail Image
Name:
1-s2.0-S2090123219301584-main.pdf
Size:
643.56 KB
Format:
Adobe Portable Document Format
Description: